ICS 2022 Scientific Podium Short Oral Session S21

ICS Members Only

Become an ICS Member today to watch

Join ICS Sign in

{{CC.VideoPaywalButtonText}} Sign in Sign in

{{CC.VideoPaywalButtonText}} Sign in

To register for this workshop please email reg_ics22@kenes.com

Purchase Gold Pass Register Sign in
Prefer to watch at your own pace, catch up on what you missed or re-watch your favourite sessions?
Extend your access to all state of the art and scientific meeting content for an extra three months, until 13 December 2022.
To purchase the gold pass please email reg_ics22@kenes.com

Restricted Video

You do not have permission to view this video

Home

Next Session All Sessions

Overactive Bladder

Scientific Podium Short Oral Session S21
Friday 9th September 2022
11:30 - 13:00 CEST
Add to calendar
- Google
- Outlook
- iCal
Hall G1. Capacity: 220
In-Person and online attendees
ICS Members OnlyRestricted Video

Marcus John Drake
ICS Chair

Sanjay Sinha
ICS Chair

Session Schedule

11:30 Fabian Queissert, Germany In-Person

#291 A single-blind, randomized, placebo controlled, prospective trial for patients with non-neurogenic overactive bladder syndrome treated with transcutaneous tibial nerve stimulation

Brücher B¹, Queissert F¹
1. Department of Urology and Pediatric Urology, University Hospital of Muenster
Clinical Trial, Neuromodulation, Overactive Bladder

11:37 Jan Krhut, Czechia In-Person

#292 Peroneal electric Transcutaneous NeuroModulation (peroneal eTNM®) is safe and effective in the treatment of the refractory overactive bladder in home-based settings

Krhut J¹, Rejchrt M², Skugarevska B¹, Slovak M³, Dvorak R³, Grepl M¹, Zvara P⁴
1. Department of Urology, University Hospital, Medical Faculty of Ostrava University, Ostrava, Czech Republic, 2. Department of Urology, 2st Faculty of Medicine of Charles University and Motol University Hospital, Prague, Czech Republic, 3. STIMVIA, Ostrava, Czech Republic, 4. Biomedical Laboratory and Research Unit of Urology, Department of Clinical Research, University of Southern Denmark, Department of Urology, University Hospital, Odense, Denmark
Prospective Study, Detrusor Overactivity, Overactive Bladder, Neuromodulation

11:45 Raquel Jácomo Online

#293 Transcutaneous electrical tibial nerve stimulation in treatment of overactive bladder syndrome in older women – randomized controlled clinical trial

Barbosa M¹, Alves A¹, Ayres D¹, De Araújo H¹, Pereira L¹, Rett M², Pequeno S¹, Souza N¹, De Lima E¹, Jácomo R³, Gomide Matheus L¹, Salata M⁴, Garcia P¹
1. Universidade de Brasilia - UnB, 2. Universidade Federal de Sergipe - UFS, 3. Hospital Universitário de Brasilia - HUB, 4. Centro Universitário do Planalto Central - UNICEPLAC
Overactive Bladder, Quality of Life (QoL), Physiotherapy, Clinical Trial, Neuromodulation

11:52 Emma Hargreaves, United Kingdom In-Person

#294 Acupuncture for Overactive Bladder in Adults: A Cochrane Review

Hargreaves E¹, Zhang Y², Zhang X², Harding C¹, Baker K³, Barry G³, Kandala N⁴, Clarkson C⁵
1. Newcastle upon Tyne Hospitals NHS Foundation Trust, 2. Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, 3. Northumbria University, 4. Warwick University, 5. Breeze Academy
Overactive Bladder, Conservative Treatment, Female, Male, Incontinence

12:00 Andika Afriansyah, Indonesia Online

#295 Biofeedback-assisted Pelvic Floor Muscle Training and Pelvic Electrical Stimulation in Women with Overactive Bladder: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Afriansyah A¹, Hami Seno D¹, Mirza H¹, Leonardo K²
1. Division of Urology, Department of Surgery, Persahabatan Hospital - Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, 2. Division of Urology, Department of Surgery, Persahabatan Hospital, Jakarta, Indonesia
Overactive Bladder, Pelvic Floor, Conservative Treatment, Physiotherapy, Quality of Life (QoL)

12:07 Howard B. Goldman In-Person

#296 Cognitive Impairment Does Not Impact Sacral Neuromodulation Implant Rates for Overactive Bladder

Zillioux J¹, Lewis K¹, Hettel D¹, Gill B¹, Goldman H¹
1. Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
Neuromodulation, Overactive Bladder, Urgency Urinary Incontinence, Gerontology

12:15 David Staskin, United States In-Person

#297 Long-Term Efficacy and Safety of Vibegron for Overactive Bladder Syndrome in Patients ≥65 Years Old: Analysis From the EMPOWUR Extension Trial

Staskin D¹, Frankel J², Varano S³, Greene H⁴, Thomas E⁴
1. Tufts University School of Medicine, 2. Seattle Urology Research Center, 3. Clinical Research Consulting, 4. Urovant Sciences
Clinical Trial, Detrusor Overactivity, Incontinence, Urgency Urinary Incontinence, Urgency/Frequency

12:22 Priya Padmanabhan, United States In-Person

#298 The Incidence of New or Worsening OAB Symptoms in Patients with Prior SARS CoV-2 Infection: A Cohort Study

Hoang Roberts L¹, Zwaans B², Peters K¹, Chancellor M¹, Padmanabhan P¹
1. Oakland University William Beaumont School of Medicine, Beaumont Hospital-Royal Oak, 2. Beaumont Hospital-Royal Oak
Infection, other, Overactive Bladder, Urgency/Frequency, Urgency Urinary Incontinence, Nocturia

12:30 Akira Furuta, Japan In-Person

#299 Differences in the bladder microbiota between men and women with or without overactive bladder

Furuta A¹, Suzuki Y², Igarashi T¹, Kimura T¹, Yoshimura N³
1. Department of Urology, Jikei University School of Medicine, Tokyo, JAPAN, 2. Department of Urology, Tokyo Rehabilitation Hospital, Tokyo, JAPAN, 3. Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Overactive Bladder, Female, Male, Infection, other, Pathophysiology

12:37 Farid Abdul Hadi Online

#300 A treatment prediction strategy for overactive bladder using a machine learning algorithm that utilised data from the FAITH study

Abdul Hadi F¹, Sumarsono B¹, Hsu Y², Cho S³, Lee K⁴, Oh S⁵, Rasner P⁶
1. Astellas Pharma Medical Affairs, Singapore, 2. Department of Urology, Linkou Chang Gung Memorial Hospital, Taipei, Taiwan, 3. Department of Urology, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea, 4. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 5. Department of Urology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea, 6. Urological Department, Moscow State University of Medicine and Dentistry, Moscow, Russia
Incontinence, Mathematical or statistical modelling, Overactive Bladder, Questionnaire, Urgency/Frequency

12:45 Diane Newman, United States In-Person

#301 Identifying Real-World Practice Patterns in Second-Line Treatments for Patients With Overactive Bladder Receiving Navigated or Routine Care From a US National Retrospective Database Study

Syan R¹, Miles-Thomas J², Abraham N³, Luo L⁴, Newman D⁵, Nelson M⁴, Enemchukwu E⁶
1. University of Miami, Miller School of Medicine, 2. Eastern Virginia Medical School, The Devine-Jordan Center for Reconstructive Surgery and Pelvic Health, 3. Montefiore Medical Center, 4. AbbVie, 5. Perelman School of Medicine, University of Pennsylvania, Penn Center for Continence and Pelvic Health, Division of Urology, 6. Stanford Multidisciplinary Pelvic Health Center, Stanford Health Care
Overactive Bladder, Retrospective Study, Incontinence

12:52 Coen Holzhauer, Netherlands In-Person

#302 The Patient Pathway for Overactive Bladder Management: A Qualitative Analysis

Holzhauer C¹, Witte L¹
1. Isala Clinics Zwolle
Quality of Life (QoL), Overactive Bladder, Urgency Urinary Incontinence

ICS Members Only

ICS Members Only

{{CC.VideoPaywallHeaderText}}

{{CC.VideoPaywallHeaderText}}

{{CC.VideoPaywallHeaderText}}

{{CC.VideoPaywallHeaderText}}

{{CC.VideoPaywallHeaderText}}

{{CC.VideoPaywallHeaderText}}

Restricted Video

Restricted Video

Overactive Bladder

Session Schedule

Comments

Live Chat